Gregg Beloff

Directeur Financier/CFO chez PANDION THERAPEUTICS, INC.

Profil

Gregg D.
Beloff is the founder of Danforth Advisors LLC, established in 2011, where the title held is Co-Managing Director.
Current jobs include Director at SG DAN Holdings LLC, President & Director at Danforth Health, Inc., Director at Formation Biologics Corp., Director at 35Pharma, Inc., Chief Financial Officer at Neurovance, Inc., and Chief Financial Officer at Pandion Therapeutics, Inc. Former jobs include Director at Bristol-Myers Squibb FCT bêta, Inc. (2018–2020), Chief Financial Officer at ImmunoGen, Inc. (2001–2003), Chief Financial Officer at Archemix Corp.
(2003–2009), Chief Financial Officer at Cerulean Pharma, Inc., Chief Financial Officer at Seres Therapeutics, Inc., Chief Financial Officer at Syros Pharmaceuticals, Inc. (2012–2014), Chief Financial Officer at Synlogic, Inc. (2019–2022), Attorney at Gaffin & Krattenmaker PC, and Chief Financial Officer at Gemini Therapeutics, Inc. Education includes an MBA from Carnegie Mellon University, undergraduate studies at Middlebury College, and graduate studies at the University of Pittsburgh Law School.

Postes actifs de Gregg Beloff

Sociétés	Poste	Début
PANDION THERAPEUTICS, INC.	Directeur Financier/CFO	-
35Pharma, Inc.	Directeur/Membre du Conseil	-
SG DAN Holdings LLC	Directeur/Membre du Conseil	-
Neurovance, Inc.	Directeur Financier/CFO	-
Danforth Advisors LLC	Fondateur	01/01/2011
Danforth Buyer, Inc.	President	-

Anciens postes connus de Gregg Beloff

Sociétés	Poste	Fin
SYNLOGIC, INC.	Directeur Financier/CFO	03/03/2022
Bristol-Myers Squibb FCT bêta, Inc.	Directeur/Membre du Conseil	21/09/2020
SYROS PHARMACEUTICALS, INC.	Directeur Financier/CFO	10/06/2014
░░░░░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░	-
░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░	-